Stephen Mitchener - SVP, Chief Business Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Business Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Mitchener since 7/7/2023

Holdings reported by Stephen Mitchener for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 128,313 $105 K $0.82 Mar 1, 2023 Direct
Stock Option (right to buy) 30,000 Aug 31, 2022 Direct Common Stock

Transactions reported by Stephen Mitchener for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership